Disclosures: Jacob Romano: Nothing to Disclose, Jessica Burnside: Nothing to Disclose, Giada Sebastiani: Novo Nordisk: Consultant, Abbvie: Speaking and Teaching, Merck: Consultant, Gilead: Speaking and Teaching, Theratechnologies Inc.: Grant/Research Support, Keyur Patel: Novo-Nordisk: Consultant, Gilead Sciences: Consultant, Merck: Consultant, Resalis: Advisor, Alnoor Ramji: Nothing to Disclose, Mark Swain: Ipsen: Advisor, Abbott: Advisor, Advanz: Advisor, Novo Nordisk: Advisor, GSK: Advisor, Ipsen: clinical trial research grant support, Novo Nordisk: clinical trial research grant support, Madrigal: clinical trial research grant support, Kowa: clinical trial research grant support, Gilead: clinical trial research grant support, Abbvie: clinical trial research grant support, Merck: clinical trial research grant support, Galectin: clinical trial research grant support, Sahar Saeed: Novo Nordisk: Consultant 1200 HELICOBACTER PYLORI CAGA/VACAS1-M1 STRAIN IS ASSOCIATED WITH HIGH RISK OF FIBROSIS IN METABOLIC-DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE Fernando Barreyro 1 Facundo Maiorana 1 Magali Neschuk 1 Maria Viriginia Caronia 1 Karina Elizondo 2 Adolfo Schneider 2 Georgina Veron 2 Pedro Dario Zapata 1 , 1 National University of Misiones, 2 Barcelo University Institute of Health Sciences Background: Recent studies have suggested an association between H
IV treatments are a quick, effective and dependable way to introduce insulin into the bloodstream
Wrist Circles: Slowly rotate wrist in circles, 10 each direction, 3 times daily Forearm Stretch: Extend arm, gently pull fingers back, hold 30 seconds Ball Squeeze (light): Gentle squeezes with soft stress ball, 10 reps, 2 times daily Supination/Pronation: Rotate forearm palm-up to palm-down, 15 reps Progressive Loading Phase (Weeks 3-6) As pain decreases and function improves, gradually introduce more challenging exercises
Cardiovascular risk2.4mg/wk The dose tested in the cardiovascular outcomes trial, which cut major adverse cardiovascular events by 20% in people with established cardiovascular disease and no diabetes
That difference is relevant
